Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.

Abstract: The invention provides an expression and secretion system, and methods of using the same, for the expression and secretion of one fusion protein in prokaryotic cells and a second fusion protein in eukaryotic cells. Also provided herein are nucleic acid molecules, vectors and host cells comprising such vectors and nucleic acid molecules.

Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.

Abstract: Renewable, non-volatile cleaning compositions incorporating ethyl ester solvents are disclosed. Preferred compositions employ non-volatile C8-16 ethyl ester solvents. All-purpose cleaning compositions incorporating the non-volatile C8-16 ethyl ester solvents, further include an alkyl polyglycoside surfactant, an alcohol ethoxylate surfactant, and water. Preferably the compositions are free of anionic, cationic and amphoteric surfactants and/or co-solvents. The invention also discloses methods employing the non-volatile solvent all-purpose cleaning compositions.

Abstract: An interactive networked classroom system including a teacher workstation with a base application, and one or more code segments. Each code segment includes a teacher version and a student version. The code segments include API links to a base application at the teacher workstation, or to helper functions such as plug-ins to the base application, such that the student version of the code segment has different rights, typically fewer and less powerful rights, than the teacher version of the same code segment. The teacher workstation forwards the student version of a code segment to student workstations that are in communication with the teacher workstation over a network facility; the student code segments may be embedded in a document corresponding to a classroom activity. Interactive classroom activities are then carried out using the code segments in combination with the base application.

Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.

Abstract: A mobile telecommunications system comprises a network of a plurality of cells and at least one user equipment device operable to communicate in the system and to operate in a first RAT and a second RAT. The method comprises, in the user equipment device, determining whether the validity of data stored on the user equipment device will expire within an expiry period, the stored data being for use in handover of operation of the user equipment device from the first RAT to the second RAT.

Abstract: A method for operating a classroom network including a host computer and a plurality of digital devices communicatively coupled to the host computer is provided. The method includes receiving student responses by the host computer from the plurality of digital devices over a period of time, wherein the student responses are generated while performing a class activity on each digital device, storing the student responses as the student responses are received, and replaying a user selected portion of the stored student responses on the host computer, wherein the replayed student responses are displayed according to a first user specified analysis view.

Abstract: The present invention is directed to compositions of matter comprising immunoconjugates comprising an anti-CD79b antibody comprising: (i) an HVR-L1 sequence of KASQSVDYEGDSFLN (SEQ ID NO: 194), (ii) an HVR-L2 sequence of AASNLES (SEQ ID NO: 195), (iii) an HVR-L3 sequence of QQSNEDPLT (SEQ ID NO: 196), (iv) an HVR-H1 sequence of GYTFSSYWIE (SEQ ID NO: 202), (v) an HVR-H2 sequence of GEILPGGGDTNYNEIFKG (SEQ ID NO: 203), and (vi) an HVR-H3 sequence of TRRVPIRLDY (SEQ ID NO: 204) and to methods of using those compositions of matter for the treatment of hematopoietic tumor in mammals.

Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.

Abstract: A method and apparatus for calculating an initial transmission power in a mobile telecommunications system is disclosed, the system comprising a network of a plurality of cells and at least one user equipment device. The user equipment device receives broadcast system information, and measures a signal power. An initial transmission power is calculated in a lowest logical layer of the system defined as a protocol stack, using the received information and measured power.

Abstract: The invention provides shuttle agents and methods of using the same to facilitate the translocation of therapeutic or diagnostic molecules into the CNS.

Abstract: The present invention relates to a solid pressed air freshener and odor neutralizer composition which can include greater than 10% fragrance. The air freshener comprises a fragrance; preferably the fragrance is impregnated within a water soluble substrate made from a foamed vegetable starch, a surfactant and a solidifier. The solid formulations break down easily in the presence of water and may be sprayed, within the area to be freshened.

Abstract: The present invention concerns antagonists of the FGF19/FGFR4 pathways, and the uses of same.

Abstract: The present invention concerns antibodies to EGFL7 and the uses of same.

Abstract: In accordance with the teachings described herein, systems and methods are provided for configuring signaling radio bearer information in a user equipment protocol stack. A wireless network may be used that includes a radio access network for transmitting information between a user equipment device and a core network. An instruction may be received to generate a signaling radio bearer configuration information element (IE) that includes configuration information for a pre-selected number of signaling radio bearers. The signaling radio bearer configuration IE may then be generated, while ensuring that the signaling radio bearer configuration IE includes configuration information for a required minimum number of signaling radio bearers. The signaling radio bearer configuration information element may be transmitted from the radio access network to the user equipment device for use in configuring the signaling radio bearers in the user equipment device.

Abstract: The present invention concerns antagonists of the FGF19/FGFR4 pathways, and the uses of same.

Abstract: The invention provides anti-mesothelin antibodies and immunoconjugates and methods of using the same.

Abstract: The present invention concerns antagonists of the FGF19/FGFR4 pathways, and the uses of same.

Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.